Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

NCT02670408 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2025-12-01

No results posted yet for this study

Summary

Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.

Conditions

  • Cardiac Transplant Disorder

Interventions

PROCEDURE

Endomyocardial biopsy

One of several endomyocardial biopsy bites taken as the standard of care. We are asking now for two endomyocardial biopsy bites, to determine tissue sampling variability.

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Philip F Halloran, MD PhD · University of Alberta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2026-12-31
Completion
2027-07-31

Countries

  • United States
  • Australia
  • Austria
  • Canada
  • Czechia
  • France
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02670408 on ClinicalTrials.gov